Prothena Corp Public (PRTA) EBIT (2012 - 2026)

Prothena Corp Public's EBIT history runs 15 years deep, the most recent figure standing at $30.0 million for Q1 2026.

• In Q1 2026, EBIT rose 145.8% year-over-year to $30.0 million; the TTM figure through Mar 2026 stood at -$119.0 million (up 14.13% YoY), while the FY2025 annual figure was -$214.6 million, down 38.87% from the prior year.
• EBIT was $30.0 million for Q1 2026 at Prothena Corp Public, up from -$24.2 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $58.4 million in Q2 2024 to a low of -$84.6 million in Q2 2025.
• Historically, EBIT has averaged -$38.9 million across 5 years, with a median of -$50.3 million in 2022.
• The sharpest annual moves came in 2023 and 2024: EBIT sank 108948.61% in 2023, then surged 187.78% in 2024.
• A 5-year view of EBIT shows it stood at -$72000.0 in 2022, then tumbled by 108948.61% to -$78.5 million in 2023, then advanced by 17.34% to -$64.9 million in 2024, then jumped by 62.71% to -$24.2 million in 2025, then jumped by 224.1% to $30.0 million in 2026.
• The last three EBIT figures came in at $30.0 million (Q1 2026), -$24.2 million (Q4 2025), and -$40.2 million (Q3 2025), per Business Quant data.